NEW ORLEANS, Dec. 15, 2017 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 5, 2018 to file lead plaintiff applications in a securities class action lawsuit against OSI Systems Inc. (Nasdaq:OSIS), if they purchased the Company’s securities between August 16, 2013 and December 6, 2017, inclusive (the “Class Period”). This action is pending in the United States District Court for the Central District of California.
Get Help
OSI Systems investors should visit us at https://www.claimsfiler.com/cases/view-osi-systems-inc-securities-litigation-1 or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
OSI Systems and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On December 6, 2017, Muddy Waters Research reported several allegations of corrupt business practices by the Company. Specifically, that an Albania concession was acquired through bribery or other improper measures; an unannounced transfer of 49% of its project company, S2 Albania SHPK, to an Albanian holding company for consideration of less than $5.00; and, based on information from former employees, other unlawful acts including improper sales, bribery and fraud.
On this news, the price of OSI Systems’ shares plummeted $24.55 per share, or 29.2%.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.


Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Washington Post Publisher Will Lewis Steps Down After Layoffs
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Anta Sports Expands Global Footprint With Strategic Puma Stake
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 



